Cargando…
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives
In recent years, clinical research has increased significantly and therapies for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis have improved. However, there are still unanswered questions and unmet needs about AAV patients. The purpose of this review is to examine the frontiers of...
Autores principales: | Quartuccio, Luca, Treppo, Elena, Urso, Livio, Del Frate, Giulia, Mescia, Federica, Alberici, Federico, Vaglio, Augusto, Emmi, Giacomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995379/ https://www.ncbi.nlm.nih.gov/pubmed/36911748 http://dx.doi.org/10.3389/fimmu.2023.1112899 |
Ejemplares similares
-
Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
por: Treppo, Elena, et al.
Publicado: (2021) -
Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases
por: Quartuccio, Luca, et al.
Publicado: (2020) -
ANCA-associated vasculitis in childhood: recent advances
por: Calatroni, Marta, et al.
Publicado: (2017) -
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial
por: Maritati, Federica, et al.
Publicado: (2017) -
Editorial: “Toward Precision Medicine in Vasculitis”
por: Alberici, Federico, et al.
Publicado: (2020)